Clinigen (Portfolio of Established Medicines) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Clinigen (Portfolio of Established Medicines) General Information

Description

Manufacturer of pharmaceutical products and services intended to treat cancer patients. The business specializes in manufacturing car dioxane, savene, totect and ethyol medicines, thereby used to reduce the cumulative renal toxicity of cisplatin in patients with advanced ovarian cancer and for reduction of the toxic effects of radiation on normal oral tissues in patients with head and neck cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Burton upon Trent
  • England, United Kingdom
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Burton upon Trent
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clinigen (Portfolio of Established Medicines) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Clinigen (Portfolio of Established Medicines)‘s full profile, request access.

Request a free trial

Clinigen (Portfolio of Established Medicines) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Clinigen (Portfolio of Established Medicines)‘s full profile, request access.

Request a free trial

Clinigen (Portfolio of Established Medicines) FAQs

  • Where is Clinigen (Portfolio of Established Medicines) headquartered?

    Clinigen (Portfolio of Established Medicines) is headquartered in Burton upon Trent, United Kingdom.

  • What industry is Clinigen (Portfolio of Established Medicines) in?

    Clinigen (Portfolio of Established Medicines)’s primary industry is Pharmaceuticals.

  • Is Clinigen (Portfolio of Established Medicines) a private or public company?

    Clinigen (Portfolio of Established Medicines) is a Private company.

  • What is Clinigen (Portfolio of Established Medicines)’s current revenue?

    The current revenue for Clinigen (Portfolio of Established Medicines) is .

  • Who are Clinigen (Portfolio of Established Medicines)’s investors?

    Clinigen has invested in Clinigen (Portfolio of Established Medicines).

  • When was Clinigen (Portfolio of Established Medicines) acquired?

    Clinigen (Portfolio of Established Medicines) was acquired on 09-Aug-2023.

  • Who acquired Clinigen (Portfolio of Established Medicines)?

    Clinigen (Portfolio of Established Medicines) was acquired by CNX Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process